Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Autor: Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S. -J., Diez-Domingo, J., Godeaux, O., Levin, M. J., Mcelhaney, J. E., Puig-Barbera, J., Vanden Abeele, C., Vesikari, T., Watanabe, D., Zahaf, T., Ahonen, A., Athan, E., Barba-Gomez, J. F., Campora, L., De Looze, F., Downey, H. J., Ghesquiere, W., Gorfinkel, I., Korhonen, T., Leung, E., Mcneil, S. A., Oostvogels, L., Rombo, L., Smetana, J., Weckx, L., Yeo, W., Heineman, T. C., Athan, E, Cunningham, Al, de Looze, F, Eizenberg, P, Yeo, W, Avelino-Silva, Tj, Neto, Jl, Santos, Rr, Weckx, L, Zerbini, Ca, Gauthier, Js, Ghesquiere, W, Gorfinkel, I, Mcelhaney, Je, Mcneil, Sa, Toma, A, Chlibek, R, Smetana, J, Poder, A, Ahonen, A, Forsten, A, Karppa, T, Korhonen, T, Seppä, I, Vesikari, T, Esen, M, Schwarz, Tf, Leung, E, Desole, Mg, Icardi, G, Pellegrino, A, Staniscia, T, Volpi, A, Ikematsu, H, Watanabe, D, Choi, Ws, Barba-Gomez, Jf, Mascarenas de Los Santos, A, Tinoco, Jc, Brotons, C, Caso, C, Diez-Domingo, J, Narejos Perez, S, Puig-Barberà, J, Rodriguez de la Pinta ML, Berglund, J, Blom, Kb, Liu, B, Pauksens, K, Rombo, L, Hwang, Sj, Thompson, A, Andrews, C, Jackson Downey, H, Freedman, M, Levin, M, Arbi, Mb, Campora, L, Catteau, G, Curran, D, Godeaux, O, Heineman, Tc, Kovac, M, Lal, H, Marion, S, Oostvogels, L, Oujaa, M, Ravault, S, Abeele, Cv, Vastiau, I, Zahaf, T, Junqueira, T, Berndtsson Blom, K, Downey, H, Rodriguez, Ml, Zerbini, C, Heineman, T, Levin, Mj, Puig, J, Heineman, Tc.

Publikováno v: NEW ENGLAND JOURNAL OF MEDICINE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

BACKGROUND A trial involving adults 50 years of age or older (ZOE-50) showed that the herpes zoster subunit vaccine (HZ/su) containing recombinant varicella-zoster virus glycoprotein E and the AS01(B) adjuvant system was associated with a risk of her

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c5eb4a935f30b7d44aa75f7253a258
https://doi.org/10.1056/nejmoa1603800

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Autor: Lal, H, Cunningham, A, Godeaux, O, Chlibek, R, Diez Domingo, J, Hwang, S, Levin, M, Mcelhaney, J, Poder, A, Puig, B, J, Vesikari, T, Watanabe, D, Weckx, L, Zahaf, T, Heineman, T, Arya, M, Athan, E, De Looze, F, Seale, J, Yeo, W, Goldani, L, Jacob, W, Luiz Neto, J, dos Santos, R, Zerbini, C, Dutz, J, Ghesquiere, W, Gorfinkel, I, Mcneil, S, Powell, C, Smetana, J, Ahonen, A, Korhonen, T, Seppa, I, Arnou, R, Beytout, J, Saillard, D, Dominicus, R, Esen, M, Plaßmann, G, Schwarz, T, Tyler, K, Hui, D, Leung, E, Pellegrino, A, Volpi, A, Endo, M, Cheong, H, Choi, W, Choo, E, Kim, Y, Lee, J, Park, D, Peck, K, Song, Y, Barba Gómez, J, de Los Santos, A, Tinoco, J, Bayas, J, Caso, C, Roure, J, Via, L, Pérez, S, López, C, Puig Barberà, J, de la Pinta, M, Riera, M, Bengnér, M, Berglund, J, Blom, K, Liu, B, Pauksens, K, Rombo, L, Chen, M, Cheng, H, Liu, C, Mcnally, D, Thompson, A, Andrews, C, Collins, H, Downey, H, Ervin, J, Freedman, M, Hoekstra, J, Hull, S, Marcadis, I, Rankin, B, Van Cleeff, M

Publikováno v: New England Journal of Medicine. 372:2087-2096

glycoprotein E and the AS01B adjuvant system (called HZ/su) had a clinically acceptable safety profile and elicited a robust immune response. METHODS: We conducted a randomized, placebo-controlled, phase 3 study in 18 countries to evaluate the effica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e818676853cfa8fad697d2cba4a1e27d
https://doi.org/10.1056/nejmoa1501184

Efficacy and safety of intra-articular injection of JTA-004, a novel supplemented protein solution, in osteoarthritic knee pain

Autor: Bettonville, M., Léon, M., Margaux, J., Urbin-Choffray, D., Theunissen, E., Besse-Hammer, T., Fortems, Y., Verlinden, S., Godeaux, O., Delmarcelle, A.-S., Kaux, J.-F.

Publikováno v: In Osteoarthritis and Cartilage April 2020 28 Supplement 1:S150-S150

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years.

Autor: Petäjä T, Keränen H, Karppa T, Kawa A, Lantela S, Siitari-Mattila M, Levänen H, Tocklin T, Godeaux O, Lehtinen M, Dubin G

Publikováno v: Journal of Adolescent Health; Jan2009, Vol. 44 Issue 1, p33-40, 8p